Integrative analyses of gene expression and DNA methylation profiles in breast cancer cell line models of tamoxifen-resistance indicate a potential role of cells with stem-like properties
Authors:
- Xue LinXLXue Lin
- Jian LiJLJian Li
- Guangliang YinGYGuangliang Yin
- Qian ZhaoQZQian Zhao
- Daniel EliasDEDaniel Elias
- Anne E LykkesfeldtALAnne E Lykkesfeldt
- Jan StenvangJSJan Stenvang
- Nils BrünnerNBNils Brünner
- Jun WangJWJun Wang
- Huanming YangHYHuanming Yang
- Lars BolundLBLars Bolund
- Henrik J DitzelHDHenrik J Ditzel
Open Access
- 19 December 2013
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research
- Vol. 15 (6) , 1-17
Abstract
Introduction: Development of resistance to tamoxifen is an important clinical issue in the treatment of breast cancer. Tamoxifen resistance may be the result of acquisition of epigenetic regulation within breast cancer cells, such as DNA methylation, resulting in changed mRNA expression of genes pivotal for estrogen-dependent growth. Alternatively, tamoxifen resistance may be due to selection of pre-existing resistant cells, or a combination of the two mechanisms. Methods: To evaluate the contribution of these possible tamoxifen resistance mechanisms, we applied modified DNA methylation-specific digital karyotyping (MMSDK) and digital gene expression (DGE) in combination with massive parallel sequencing to analyze a well-established tamoxifen-resistant cell line model (TAMR), consisting of 4 resistant and one parental cell line. Another tamoxifen-resistant cell line model system (LCC1/LCC2) was used to validate the DNA methylation and gene expression results. Results: Significant differences were observed in global gene expression and DNA methylation profiles between the parental tamoxifen-sensitive cell line and the 4 tamoxifen-resistant TAMR sublines. The 4 TAMR cell lines exhibited higher methylation levels as well as an inverse relationship between gene expression and DNA methylation in the promoter regions. A panel of genes, including NRIP1, HECA and FIS1, exhibited lower gene expression in resistant vs. parental cells and concurrent increased promoter CGI methylation in resistant vs. parental cell lines. A major part of the methylation, gene expression, and pathway alterations observed in the TAMR model were also present in the LCC1/LCC2 cell line model. More importantly, high expression of SOX2 and alterations of other SOX and E2F gene family members, as well as RB-related pocket protein genes in TAMR highlighted stem cell-associated pathways as being central in the resistant cells and imply that cancer-initiating cells/cancer stem-like cells may be involved in tamoxifen resistance in this model. Conclusion: Our data highlight the likelihood that resistant cells emerge from cancer-initiating cells/cancer stem-like cells and imply that these cells may gain further advantage in growth via epigenetic mechanisms. Illuminating the expression and DNA methylation features of putative cancer-initiating cells/cancer stem cells may suggest novel strategies to overcome tamoxifen resistance.Keywords
This publication has 65 references indexed in Scilit:
- Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trialsThe Lancet, 2011
- Mechanisms of Endocrine Resistance in Breast CancerAnnual Review of Medicine, 2011
- Biological determinants of endocrine resistance in breast cancerNature Reviews Cancer, 2009
- Estrogen Receptor analyses in the Danish Breast Cancer Cooperative Group. History, methods, prognosis and clinical implicationsActa Oncologica, 2008
- Selective Estrogen-Receptor Modulators and Antihormonal Resistance in Breast CancerJournal of Clinical Oncology, 2007
- Mechanisms of tamoxifen resistanceEndocrine-Related Cancer, 2004
- Antiestrogen resistance in breast cancer and the role of estrogen receptor signalingOncogene, 2003
- Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.Journal of Clinical Oncology, 1984
- EFFECTS OF ESTROGENS AND ANTIESTROGENS ON HORMONE-RESPONSIVE HUMAN BREAST-CANCER IN LONG-TERM TISSUE-CULTURE1976
- A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2JNCI: Journal of the National Cancer Institute, 1973